AstraZeneca metastatic breast cancer treatment secures FDA approval May 10, 2022 Auto Bot Markets & Regulations 0 The US agency has approved Enhertu for patients diagnosed with HER2-positive metastatic breast cancer previously treated with an anti-HER2-based regimen.
